4//SEC Filing
Marks Gilbert Lynn 4
Accession 0000899243-23-015314
CIK 0001880438other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 8:44 PM ET
Size
9.1 KB
Accession
0000899243-23-015314
Insider Transaction Report
Form 4
Marks Gilbert Lynn
Director
Transactions
- Award
Stock Option (right to buy)
2023-06-07+23,742→ 23,742 totalExercise: $5.91Exp: 2033-06-06→ Common Stock (23,742 underlying)
Footnotes (1)
- [F1]The option shares shall vest on the earlier of (a) the one-year anniversary of June 7, 2023 or (b) the day prior to the date of the Issuer's next annual stockholder meeting, subject to the Reporting Person providing continuous service through such vesting date.
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeother
Related Parties
1- filerCIK 0001916940
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 8:44 PM ET
- Size
- 9.1 KB